INE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.989600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.493800E-01
Normal-vs-Stage2
7.141000E-01
Normal-vs-Stage3
5.564400E-01
Normal-vs-Stage4
5.536800E-01
Stage1-vs-Stage2
9.539000E-01
Stage1-vs-Stage3
7.907000E-01
Stage1-vs-Stage4
8.325800E-01
Stage2-vs-Stage3
6.295200E-01
Stage2-vs-Stage4
7.135600E-01
Stage3-vs-Stage4
9.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.050800E-01
Normal-vs-AfricanAmerican
5.732000E-01
Normal-vs-Asian
4.292000E-01
Caucasian-vs-AfricanAmerican
7.406200E-01
Caucasian-vs-Asian
6.872200E-01
AfricanAmerican-vs-Asian
9.804000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.545200E-01
Normal-vs-Female
7.617200E-01
Male-vs-Female
1.666610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.520600E-01
Normal-vs-Age(41-60Yrs)
7.270400E-01
Normal-vs-Age(61-80Yrs)
4.089800E-01
Normal-vs-Age(81-100Yrs)
6.083200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.495000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.975200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.790600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.625200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.067400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.632600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.365400E-01
Normal-vs-Daily Drinker
6.577000E-01
Normal-vs-Weekly Drinker
7.522400E-01
Normal-vs-Occasional Drinker
6.516600E-01
Normal-vs-Social Drinker
8.828000E-01
Non Drinker-vs-Daily Drinker
8.634400E-01
Non Drinker-vs-Weekly Drinker
4.246800E-01
Non Drinker-vs-Occasional Drinker
9.073000E-01
Non Drinker-vs-Social Drinker
1.699980E-01
Daily Drinker-vs-Weekly Drinker
4.965400E-01
Daily Drinker-vs-Occasional Drinker
9.632200E-01
Daily Drinker-vs-Social Drinker
1.877240E-01
Weekly Drinker-vs-Occasional Drinker
4.799800E-01
Weekly Drinker-vs-Social Drinker
7.248200E-01
Occasional Drinker-vs-Social Drinker
1.923180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.693180E-01
Normal-vs-Grade 2
4.550300E-02
Normal-vs-Grade 3
1.185170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.422800E-01
Grade 1-vs-Grade 3
2.572200E-01
Grade 1-vs-Grade 4
1.693180E-01
Grade 2-vs-Grade 3
7.080000E-01
Grade 2-vs-Grade 4
4.550300E-02
Grade 3-vs-Grade 4
1.185170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.858600E-01
Normal-vs-NonDiabetic
7.297000E-01
Diabetic-vs-NonDiabetic
4.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.996400E-01
Normal-vs-NoPancreatitis
6.847600E-01
Pancreatitis-vs-NoPancreatitis
2.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.045200E-01
Normal-vs-N1
6.895600E-01
N0-vs-N1
8.728000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.798600E-01
Normal-vs-TP53-NonMutant
4.327400E-01
TP53-Mutant-vs-TP53-NonMutant
6.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
